Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Safety and Efficacy of Mucinex D for Symptomatic Therapy in Patients With Acute Upper Respiratory Tract Who Seek Treatment

NCT01202279 is registered in ClinicalTrials.gov with Reckitt Benckiser Inc. as lead sponsor.

NCT NCT01202279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01202279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Safety and Efficacy of Mucinex D for Symptomatic Therapy in Patients With Acute Upper Respiratory Tract Who Seek Treatment
Lead sponsor
Reckitt Benckiser Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2009
Completion date
July 31, 2010
Enrollment
1,179 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper respiratory track infection